Unusual astrocyte reactivity caused by the food mycotoxin ochratoxin A in aggregating rat brain cell cultures
Related Experiment Video
Updated: Aug 17, 2026

A Neuronal and Astrocyte Co-Culture Assay for High Content Analysis of Neurotoxicity
Published on: May 5, 2009
M-G Zurich1, S Lengacher, O Braissant
1Department of Physiology, University of Lausanne, Rue du Bugnon 7, CH-1005 Lausanne, Switzerland. mzurich@unil.ch
Abstract:
Ochratoxin A (OTA), a mycotoxin and widespread food contaminant, is known for its patent nephrotoxicity and potential neurotoxicity. Previous observations in vitro showed that in the CNS, glial cells were particularly sensitive to OTA. In the search for the molecular mechanisms underlying OTA neurotoxicity, we investigated the relationship between OTA toxicity and glial reactivity, in serum-free aggregating brain cell cultures. Using quantitative reverse transcriptase-polymerase chain reaction to analyze changes in gene expression, we found that in astrocytes, non cytotoxic concentrations of OTA down-regulated glial fibrillary acidic protein, while it up-regulated vimentin and the peroxisome proliferator-activated receptor-gamma expression. OTA also up-regulated the inducible nitric oxide synthase and the heme oxygenase-1. These OTA-induced alterations in gene expression were more pronounced in cultures at an advanced stage of maturation. The natural peroxisome proliferator-activated receptor-gamma ligand, 15-deoxy-delta(12,14) prostaglandin J2, and the cyclic AMP analog, bromo cyclic AMP, significantly attenuated the strong induction of peroxisome proliferator-activated receptor-gamma and inducible nitric oxide synthase, while they partially reversed the inhibitory effect of OTA on glial fibrillary acidic protein. The present results show that OTA affects the cytoskeletal integrity of astrocytes as well as the expression of genes pertaining to the brain inflammatory response system, and suggest that a relationship exists between the inflammatory events and the cytoskeletal changes induced by OTA. Furthermore, these results suggest that, by inducing an atypical glial reactivity, OTA may severely affect the neuroprotective capacity of glial cells.
Insights
Ochratoxin A (OTA) alters astrocyte gene expression, affecting cytoskeletal integrity and brain inflammation. This mycotoxin may impair glial cells' neuroprotective functions.
Area of Science:
- Neuroscience
- Toxicology
- Cell Biology
Background:
- Ochratoxin A (OTA) is a mycotoxin and food contaminant known for kidney toxicity and potential neurotoxicity.
- Glial cells in the central nervous system (CNS) are particularly sensitive to OTA.
- Understanding the molecular mechanisms of OTA neurotoxicity requires investigating its effects on glial reactivity.
Purpose of the Study:
- To investigate the relationship between Ochratoxin A (OTA) toxicity and glial reactivity in brain cell cultures.
- To identify molecular changes in astrocytes exposed to non-cytotoxic concentrations of OTA.
Main Methods:
- Utilized serum-free aggregating brain cell cultures.
- Employed quantitative reverse transcriptase-polymerase chain reaction (RT-qPCR) to analyze gene expression changes.
- Assessed the effects of OTA on astrocyte-specific genes, inflammatory response genes, and peroxisome proliferator-activated receptor-gamma (PPARγ) pathway.
Main Results:
- Non-cytotoxic OTA concentrations down-regulated glial fibrillary acidic protein (GFAP) while up-regulating vimentin and PPARγ in astrocytes.
- OTA also induced the expression of inducible nitric oxide synthase (iNOS) and heme oxygenase-1 (HO-1).
- These alterations were more pronounced in mature cultures and could be partially reversed by PPARγ ligands and cAMP analogs.
Conclusions:
- OTA impacts astrocyte cytoskeletal integrity and modulates genes involved in the brain's inflammatory response.
- A link exists between OTA-induced inflammatory events and cytoskeletal alterations in astrocytes.
- OTA may compromise the neuroprotective capacity of glial cells by inducing atypical glial reactivity.

